Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
New England Journal of Medicine · 25.07.2024 · 391 (4) · 320-333
DOI: 10.1056/nejmoa2312948 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 25.07.2024. Verfasst von Mark R Litzow und 41 weiteren Autor:innen. Beteiligte Einrichtung: From the Mayo Clinic, Rochester, MN (M.R.L., C.L.W., M.A.E.); Dana-Farber Cancer Institute, Boston (Z.S., D.J.D., R.M.S.); the University of Wisconsi…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasm, Residual, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 301-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, ECOG-ACRIN Cancer Research Group.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Mayo Clinic, Rochester, MN (M.R.L., C.L.W., M.A.E.); Dana-Farber Cancer Institute, Boston (Z.S., D.J.D., R.M.S.); the University of Wisconsin Carbone Cancer Center, Madison (R.J.M.), and the Medical College of…
ORCID-Profile: Charles G Mullighan
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- ECOG-ACRIN Cancer Research Group
- NIGMS NIH HHS
Zitieren
APA
Litzow, M. R., Sun, Z., Mattison, R. J., Paietta, E. M., Roberts, K. G., Zhang, Y., Racevskis, J., Lazarus, H. M., Rowe, J. M., Arber, D. A., Wieduwilt, M. J., Liedtke, M., Bergeron, J., Wood, B. L., Zhao, Y., Wu, G., Chang, T. C., Zhang, W., Pratz, K. W., …, & Tallman, M. S. (2024). Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. New England Journal of Medicine, 391(4), 320-333. https://doi.org/10.1056/nejmoa2312948
Vancouver
Litzow MR, Sun Z, Mattison RJ, Paietta EM, Roberts KG, Zhang Y, et al. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. New England Journal of Medicine. 2024;391(4):320-333. doi:10.1056/nejmoa2312948
BibTeX
@article{Litzow2024,
author = {Litzow, Mark R and Sun, Zhuoxin and Mattison, Ryan J and Paietta, Elisabeth M and Roberts, Kathryn G and Zhang, Yanming and Racevskis, Janis and Lazarus, Hillard M and Rowe, Jacob M and Arber, Daniel A and Wieduwilt, Matthew J and Liedtke, Michaela and Bergeron, Julie and Wood, Brent L and Zhao, Yaqi and Wu, Gang and Chang, Ti-Cheng and Zhang, Wenchao and Pratz, Keith W and Dinner, Shira N and Frey, Noelle and Gore, Steven D and Bhatnagar, Bhavana and Atallah, Ehab L and Uy, Geoffrey L and Jeyakumar, Deepa and Lin, Tara L and Willman, Cheryl L and DeAngelo, Daniel J and Patel, Shejal B and Elliott, Michelle A and Advani, Anjali S and Tzachanis, Dimitrios and Vachhani, Pankit and Bhave, Rupali R and Sharon, Elad and Little, Richard F and Erba, Harry P and Stone, Richard M and Luger, Selina M and Mullighan, Charles G and Tallman, Martin S},
title = {Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {4},
pages = {320--333},
doi = {10.1056/nejmoa2312948}
}
EUVIMED